Bio-Path Holdings, Inc. (BPTH) analyst actions
Rating and price-target actions on BPTH in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BPTH overview →
1 measured BPTH analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity | Press release | +3.89% | -7.03% |
Keep exploring
More BPTH: earnings → · SEC filings → · BPTH overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ESSILOR LXTTCA UNSP/ADR (ESLOY) | 169 | -0.01% | 45% |
| BODY AND MIND INC (BMMJ) | 168 | 0.00% | 31% |
| Iterum Therapeutics plc - Ordinary Share (ITRM) | 168 | 0.00% | 49% |
| BIOSTAR PHARMS INC (BSPM) | 167 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.